ArticleNeoplasia (New York, N.Y.)2024

RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells.

Fengxu Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.